Prostate Cancer Clinical Trial

Decision Support Interventions (DESI) for Prostate Cancer Screening – Study 1

Summary

In this study we will compare 3 strategies for systematic delivery of prostate cancer screening decision support interventions (DESI) to usual care and examine their impact on screening decisions and subsequent healthcare utilization using a randomized control design.

We hypothesize men who are given the opportunity to review a DESI by one of the 3 strategies will be less likely to opt for prostate cancer screening, and will have lower subsequent healthcare utilization than men in the control group.

View Full Description

Full Description

We will use a randomized experimental design to compare the effects of 3 different strategies to implement a prostate cancer screening decision support intervention (DESI) with a control condition in primary care in 2 clinical systems - PAMF (Palo Alto Medical Foundation) and UNC. The primary outcomes of interest are men's screening decisions and their subsequent healthcare utilization. Secondary outcomes include the likelihood that they review the DESI and their decision-specific knowledge. The 3 strategies selected by the PAMF and UNC health systems are: (1) mailing men a DESI in DVD; (2) inviting men to participate in a shared (group) medical appointment (SMA) to watch and discuss the DESI with a healthcare provider and other men; and (3) providing men options by inviting them to a SMA while also providing them a DESI in DVD which they can use individually if they are unable or choose not to attend a SMA. The 3 groups will be compared to a control condition that does not receive a DESI but will be encouraged to discuss prostate cancer screening with their physician. Because of its significantly larger patient population, the PAMF site will also evaluate these outcomes by targeting screening-naïve patients on their 50th birthday, when they first become guideline eligible to consider prostate cancer screening.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

age 50 or older
do not have a prostate diagnosis
have not had a PSA test in the past 10 months
have not seen their primary care physicians in the last 3 months

Exclusion Criteria:

Women

Study is for people with:

Prostate Cancer

Estimated Enrollment:

2521

Study ID:

NCT01241656

Recruitment Status:

Completed

Sponsor:

University of North Carolina, Chapel Hill

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Palo Alto Medical Foundation Research Institute
Palo Alto California, 94301, United States
University of North Carolina, Chapel Hill
Chapel Hill North Carolina, 27599, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

2521

Study ID:

NCT01241656

Recruitment Status:

Completed

Sponsor:


University of North Carolina, Chapel Hill

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider